article thumbnail

Ensuring Quality and Compliance: A Guide to 21 CFR Part 212 for PET Drug Manufacturing

Open Medscience

The regulations in 21 CFR Part 212 ensure PET drugs are manufactured under strict quality control and safety standards. The post Ensuring Quality and Compliance: A Guide to 21 CFR Part 212 for PET Drug Manufacturing appeared first on Open MedScience.

article thumbnail

Meet the Minnies 2024 finalists

AuntMinnie

In any case, for Pickhardt, research is key to providing high-quality patient care. "I Beyder played a key role in launching the radiopharmaceutical therapy (RPT) comprehensive center of excellence at WU, BJH, and Siteman Cancer Center last year.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The International Council for Harmonization (ICH) Q10: A Model for a Robust Pharmaceutical Quality Management System

Open Medscience

ICH Q10 is a global model for managing pharmaceutical quality, ensuring compliance, continuous improvement, and risk manage The post The International Council for Harmonization (ICH) Q10: A Model for a Robust Pharmaceutical Quality Management System appeared first on Open MedScience.

article thumbnail

RLS Radiopharmacies Partners with Eckert and Ziegler to Expand Production of Gallium-68-Based Radiopharmaceuticals

Imaging Technology

milla1cf Fri, 04/05/2024 - 11:31 April 5, 2024 — RLS Radiopharmacies , America’s only Joint Commission-accredited radiopharmacy network, today announced it has expanded its radiopharmaceutical contract development and manufacturing (rCDMO) capabilities by entering into a strategic agreement with global isotope technology leader Eckert & Ziegler.

article thumbnail

TeleDaaS Launches as Premier Provider of Dosimetry as a Service for Clinical Research Organizations

Imaging Technology

Radiopharmaceuticals are revolutionizing modern cancer treatment and precision dosimetry is a crucial component of this advanced therapy. This is already showing promise with several ongoing trials of approved and developmental radiopharmaceuticals. TeleDaaS licenses a cloud-based technology platform from Mirada Medical.

Clinic 78